The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 28, 2020

Filed:

Dec. 22, 2015
Applicants:

University of Iowa Research Foundation, Iowa City, IA (US);

Paloma H. Giangrande, Iowa City, IA (US);

Kevin Urak, Iowa City, IA (US);

Inventors:

Paloma H. Giangrande, Iowa City, IA (US);

Francis Miller, Iowa City, IA (US);

Kevin Urak, Iowa City, IA (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/115 (2010.01); C07H 21/02 (2006.01); A61P 29/02 (2006.01); A61K 9/00 (2006.01);
U.S. Cl.
CPC ...
C07H 21/02 (2013.01); A61K 9/007 (2013.01); A61K 9/0019 (2013.01); A61P 29/02 (2018.01); C12N 15/115 (2013.01); C12N 2310/16 (2013.01); C12N 2310/321 (2013.01);
Abstract

The present invention relates to methods of using optimized aptamers. In certain embodiments, the present invention provides a method for treating a subject having or being disposed to having a histone-induced injury or disease comprising administering to the subject a pharmaceutical composition comprising a pharmaceutically acceptable carrier and (i) a nucleic acid molecule not more than 90 nucleotides in length comprising an aptamer KU1, KU2, KU3, KU4, KU5, KU6, KU&, KU8, or KU9, wherein the aptamer specifically targets extracellular histones, wherein the nucleotides are RNA; or (ii) a conjugate comprising a nucleic acid molecule not more than 90 nucleotides in length comprising an aptamer KU1, KU2, KU3, KU4, KU5, KU6, KU&, KU8, or KU9, wherein the aptamer specifically targets extracellular histones, wherein the nucleotides are RNA, wherein the nucleic acid molecule is linked to a therapeutic molecule.


Find Patent Forward Citations

Loading…